
Acquired company lasted less than a year after Biogen spinoff
Acquired company lasted less than a year after Biogen spinoff
HDA 2017-8 Factbook details rising wholesaler involvement
Acquisition brings retail pharmacy and PBM together with a health insurer
Private equity firm acquires UBC
The Netherlands wins out in the competition to move the agency from London
$815-million deal to close in early 2018
Rumors of a $60-billion acquisition shake up healthcare services landscape—and what about Amazon?
New identity stresses ‘human data science’
Revised deal brings 1,932 stores to Walgreens Boots Alliance
Bloomington, IN, facility is the prize
‘An unaffordable drug is 100 percent ineffective’
First gene therapy product in US; approval expedited by evidence of high cure rates
Investors hope for a repeat of Gilead’s Sovaldi success
Observers are critical of the $465-million penalty as too lenient
Leading CRO looks to better trial recruitment, outcomes research
A protest against not protesting; unclear consequences for pharma’s place on the White House council
New location, following Brexit, will be decided in November
GPO for academic medical centers and other providers
Cambridge BioMarketing brings orphan-drug expertise, and Vynamic brings branding and launch services
Assn. for Accessible Medicines files a federal suit against the state
Fourth annual meeting will occur Oct. 16-17